Literature DB >> 17005558

Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket.

Sabine Höpner1, Katharina Dickhaut, Maria Hofstätter, Heiko Krämer, Dominik Rückerl, J Arvid Söderhäll, Shashank Gupta, Viviana Marin-Esteban, Ronald Kühne, Christian Freund, Günther Jung, Kirsten Falk, Olaf Rötzschke.   

Abstract

Major histocompatibility complex (MHC) molecules are a key element of the cellular immune response. Encoded by the MHC they are a family of highly polymorphic peptide receptors presenting peptide antigens for the surveillance by T cells. We have shown that certain organic compounds can amplify immune responses by catalyzing the peptide loading of human class II MHC molecules HLA-DR. Here we show now that they achieve this by interacting with a defined binding site of the HLA-DR peptide receptor. Screening of a compound library revealed a set of adamantane derivatives that strongly accelerated the peptide loading rate. The effect was evident only for an allelic subset and strictly correlated with the presence of glycine at the dimorphic position beta86 of the HLA-DR molecule. The residue forms the floor of the conserved pocket P1, located in the peptide binding site of MHC molecule. Apparently, transient occupation of this pocket by the organic compound stabilizes the peptide-receptive conformation permitting rapid antigen loading. This interaction appeared restricted to the larger Gly(beta86) pocket and allowed striking enhancements of T cell responses for antigens presented by these "adamantyl-susceptible" MHC molecules. As catalysts of antigen loading, compounds targeting P1 may be useful molecular tools to amplify the immune response. The observation, however, that the ligand repertoire can be affected through polymorphic sites form the outside may also imply that environmental factors could induce allergic or autoimmune reactions in an allele-selective manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005558     DOI: 10.1074/jbc.M606437200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

2.  Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.

Authors:  Aaron W Michels; David A Ostrov; Li Zhang; Maki Nakayama; Masanori Fuse; Kristen McDaniel; Bart O Roep; Peter A Gottlieb; Mark A Atkinson; George S Eisenbarth
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

3.  Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs.

Authors:  Waqasuddin Khan
Journal:  J Comput Aided Mol Des       Date:  2010-11-30       Impact factor: 3.686

Review 4.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

5.  In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange.

Authors:  Melissa J Call; Xuechao Xing; Gregory D Cuny; Nilufer P Seth; Daniel M Altmann; Lars Fugger; Michelle Krogsgaard; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

6.  Characterization of structural features controlling the receptiveness of empty class II MHC molecules.

Authors:  Bernd Rupp; Sebastian Günther; Talat Makhmoor; Andreas Schlundt; Katharina Dickhaut; Shashank Gupta; Iqbal Choudhary; Karl-Heinz Wiesmüller; Günther Jung; Christian Freund; Kirsten Falk; Olaf Rötzschke; Ronald Kühne
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

7.  The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01.

Authors:  Makoto Hirasawa; Katsunobu Hagihara; Noriko Okudaira; Takashi Izumi
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens.

Authors:  Sandra Rosskopf; Sabrina Jutz; Alina Neunkirchner; Martín R Candia; Beatrice Jahn-Schmid; Barbara Bohle; Winfried F Pickl; Peter Steinberger
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

9.  Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE).

Authors:  Katharina Dickhaut; Sabine Hoepner; Jamina Eckhard; Karl-Heinz Wiesmueller; Luise Schindler; Guenther Jung; Kirsten Falk; Olaf Roetzschke
Journal:  PLoS One       Date:  2009-09-07       Impact factor: 3.240

10.  Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules.

Authors:  Shashank Gupta; Sabine Höpner; Bernd Rupp; Sebastian Günther; Katharina Dickhaut; Noopur Agarwal; M Cristina Cardoso; Ronald Kühne; Karl-Heinz Wiesmüller; Günther Jung; Kirsten Falk; Olaf Rötzschke
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.